SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop

LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer

(2018) Yang Liu et al.   Biochemistry and Cell Biology

Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p

(2018) Qingchun Lu et al.   FASEB JOURNAL

circ-SHKBP1 Regulates the Angiogenesis of U87 Glioma-Exposed Endothelial Cells through miR-544a/FOXP1 and miR-379/FOXP2 Pathways

(2018) Qianru He et al.   Molecular Therapy-Nucleic Acids

The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p

(2018) Mu Xu et al.   Molecular Cancer

Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway

(2017) Yang Nan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer

(2017) Manmei Long et al.   Molecular Cancer

H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells

(2017) Runsheng He et al.   NUCLEIC ACIDS RESEARCH

The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes

(2017) Y Sun et al.   ONCOGENE

Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis

(2017) S Deguchi et al.   ONCOGENE

MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH

(2017) Wenhui Qiao et al.   Oncology Letters

miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2

(2017) Xian-Lu Song et al.   Journal of Cancer

Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis

(2016) Min Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

(2016) Oluwaseun Adebayo Bamodu et al.   BMC CANCER

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

(2016) Michele Ceccarelli et al.   CELL

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma

(2016) LIPING FANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance

(2016) Lingling Wang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells

(2016) Hao Teng et al.   MOLECULAR THERAPY

Progress in glioma diagnosis, classification and treatment

(2016) Patrick Y. Wen et al.   Nature Reviews Neurology

Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma

(2016) H Cai et al.   ONCOGENE

miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

(2016) XINGYU LIN et al.   Oncology Letters

lncRNA-RNA Interactions across the Human Transcriptome

(2016) Michał Wojciech Szcześniak et al.   PLoS One

Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus

(2015) Mariusz Adam Goscinski et al.   APMIS

The emerging role of lysine demethylases in DNA damage response: dissecting the recruitment mode of KDM4D/JMJD2D to DNA damage sites

(2015) Hanan Khoury-Haddad et al.   CELL CYCLE

The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation

(2015) Leslie J. Meredith et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion

(2015) Xia Yan et al.   TUMOR BIOLOGY

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer

(2015) Lishuang Wang et al.   TUMOR BIOLOGY

JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells

(2015) Yung-Ting Kuo et al.   PLoS One

Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21

(2014) Bin Dai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Histone demethylase KDM5B is a key regulator of genome stability

(2014) X. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma

(2012) Ling-Ling Sun et al.   ACTA HISTOCHEMICA

miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1

(2012) Gozde Korkmaz et al.   Autophagy

Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor

(2012) Line H. Kristensen et al.   FEBS Journal

Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells

(2012) Yukti Choudhury et al.   JOURNAL OF CLINICAL INVESTIGATION

Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway

(2010) Shinya Hayami et al.   Molecular Cancer

Frequency and fate of microRNA editing in human brain

(2008) Y. Kawahara et al.   NUCLEIC ACIDS RESEARCH